{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:06:54Z","timestamp":1793387214998,"version":"4.5.0"},"reference-count":69,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Chronic viral hepatitis B and C remain major global health challenges, contributing significantly to liver-related morbidity and mortality. Despite antiviral therapies and vaccines for HBV, progression to cirrhosis and hepatocellular carcinoma remains common. For HCV, the lack of a vaccine and high chronicity rates further complicate outcomes. Recent evidence highlights gut\u2013liver axis dysfunction and microbiota dysbiosis in disease progression, immune dysregulation, and fibrosis. Notably, alterations in microbiota composition, including reduced commensal bacteria such as Bifidobacteria and Lactobacilli and an increase in putatively harmful Enterobacteriaceae and Veillonellaceae, have been observed in HBV\/HCV infections and cirrhosis. While antiviral therapies do not directly target the gut microbiota, they can contribute to partial restoration of microbial balance by reducing hepatic inflammation and improving gut\u2013liver axis integrity. Nonetheless, post-treatment patients remain at elevated risk of HCC due to persistent epigenetic and immune-mediated changes. Emerging interventions, including probiotic strains, prebiotics, and symbiotics, demonstrate potential in enhancing gut health, alleviating inflammation, and enhancing the quality of life for liver disease patients. Moreover, the gut microbiota is gaining increasing recognition as a potential non-invasive biomarker for early disease detection and monitoring. Ultimately, modulating the gut microbiota could become an integral component of future strategies for managing chronic liver diseases and preventing their complications.<\/jats:p>","DOI":"10.3390\/microorganisms13051053","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:10:32Z","timestamp":1746076232000},"page":"1053","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Gut Microbiota and the Gut\u2013Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies"],"prefix":"10.3390","volume":"13","author":[{"given":"Sniedze","family":"Laivacuma","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Department of Infectology, R\u012bga Stradi\u0146\u0161 University, 16 Dzirciema Str., LV-1007 Riga, Latvia"},{"name":"Riga East University Hospital, 2 Hipokrata Str., LV-1079 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Oblate","sequence":"additional","affiliation":[{"name":"Department of Residency, R\u012bga Stradi\u0146\u0161 University, 16 Dzirciema Str., LV-1007 Riga, Latvia"},{"name":"Faculty of Medicine, Department of Internal Diseases, R\u012bga Stradi\u0146\u0161 University, 16 Dzirciema Str., LV-1007 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0252-0726","authenticated-orcid":false,"given":"Aleksejs","family":"Derovs","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Infectology, R\u012bga Stradi\u0146\u0161 University, 16 Dzirciema Str., LV-1007 Riga, Latvia"},{"name":"Riga East University Hospital, 2 Hipokrata Str., LV-1079 Riga, Latvia"},{"name":"Faculty of Medicine, Department of Internal Diseases, R\u012bga Stradi\u0146\u0161 University, 16 Dzirciema Str., LV-1007 Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2361963","DOI":"10.1155\/2018\/2361963","article-title":"The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection","volume":"2018","author":"Yang","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"198203","DOI":"10.1016\/j.virusres.2020.198203","article-title":"Is it time for microbiome-based therapies in viral infections?","volume":"291","author":"Sadiq","year":"2021","journal-title":"Virus Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00430-014-0370-1","article-title":"Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection","volume":"204","author":"Zhang","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1073\/pnas.1424775112","article-title":"Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota","volume":"112","author":"Chou","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sim\u00e3o, M., and Gon\u00e7alves, C. (2024). Hepatitis C Virus Infection in Europe. Pathogens, 13.","DOI":"10.3390\/pathogens13100841"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hayes, C.N., Zhang, P., Zhang, Y., and Chayama, K. (2018). Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection. Viruses, 10.","DOI":"10.3390\/v10100531"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17474124.2019.1569513","article-title":"Gut microbiota: Novel therapeutic target for nonalcoholic fatty liver disease","volume":"13","author":"Suk","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"El-Mowafy, M., Elgaml, A., El-Mesery, M., Sultan, S., Ahmed, T.A.E., Gomaa, A.I., Aly, M., and Mottawea, W. (2021). Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection. Biology, 10.","DOI":"10.3390\/biology10010055"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez, M.F., Reina-P\u00e9rez, I., Astorga, J.M., Rodr\u00edguez-Carrillo, A., Plaza-D\u00edaz, J., and Fontana, L. (2018). Breast Cancer and Its Relationship with the Microbiota. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15081747"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Raimondi, S., Amaretti, A., Gozzoli, C., Simone, M., Righini, L., Candeliere, F., Brun, P., Ardizzoni, A., Colombari, B., and Paulone, S. (2019). Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.01575"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sehgal, R., Bedi, O., and Trehanpati, N. (2020). Role of Microbiota in Pathogenesis and Management of Viral Hepatitis. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00341"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.3748\/wjg.v27.i43.7446","article-title":"Overview of the microbiota in the gut-liver axis in viral B and C hepatitis","volume":"27","author":"Neag","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Peroni, D.G., Nuzzi, G., Trambusti, I., Di Cicco, M.E., and Comberiati, P. (2020). Microbiome Composition and Its Impact on the Development of Allergic Diseases. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00700"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.21037\/hbsn.2019.09.04","article-title":"Potential therapeutic strategies to target gut microbiota in hepatocellular carcinoma","volume":"8","author":"Amedei","year":"2019","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Todorovic, N., Martinelli, S., Nannini, G., Weiskirchen, R., and Amedei, A. (2024). Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413510"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejim.2019.06.005","article-title":"Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients","volume":"67","author":"Morano","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1038\/s41467-019-13721-1","article-title":"Relationship between gut microbiota and circulating metabolites in population-based cohorts","volume":"10","author":"Vojinovic","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cbi.2018.01.004","article-title":"Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition","volume":"282","author":"Patel","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/apt.15004","article-title":"Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis","volume":"48","author":"Ponziani","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/imr.12567","article-title":"Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease","volume":"279","author":"Pickard","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13099-019-0337-2","article-title":"The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption","volume":"11","author":"Deng","year":"2019","journal-title":"Gut Pathog."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., and Lekic, N. (2019). Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020395"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wang, J., Wang, Y., Zhang, X., Liu, J., Zhang, Q., Zhao, Y., Peng, J., Feng, Q., Dai, J., and Sun, S. (2017). Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.02222"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Yun, Y., Chang, Y., Kim, H.-N., Ryu, S., Kwon, M.-J., Cho, Y.K., Kim, H.-L., Cheong, H.S., and Joo, E.-J. (2019). Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level. J. Clin. Med., 8.","DOI":"10.3390\/jcm8020173"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Gupta, H., Youn, G.S., Shin, M.J., and Suk, K.T. (2019). Role of Gut Microbiota in Hepatocarcinogenesis. Microorganisms, 7.","DOI":"10.20944\/preprints201903.0267.v1"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/cid\/ciy205","article-title":"Gut dysbiosis associated with hepatitis C virus infection","volume":"67","author":"Inoue","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13099-016-0124-2","article-title":"Gut microbiome alterations in patients with stage 4 hepatitis C","volume":"8","author":"Aly","year":"2016","journal-title":"Gut Pathog."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lee, N.Y., and Suk, K.T. (2020). The Role of the Gut Microbiome in Liver Cirrhosis Treatment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010199"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Hsu, Y.C., Chen, C.C., Lee, W.H., Chang, C.Y., Lee, F.J., Tseng, C.H., Chen, T.H., Ho, H.J., Lin, J.T., and Wu, C.Y. (2022). Compositions of gut microbiota before and shortly after hepatitis C viral eradication by direct antiviral agents. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-09534-w"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jfma.2022.08.022","article-title":"Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C","volume":"122","author":"Huang","year":"2023","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/infdis\/jiab094","article-title":"Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients with or Without Human Immunodeficiency Virus Coinfection","volume":"224","author":"Chuaypen","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40121-020-00355-w","article-title":"Effect of Entecavir on the Intestinal Microflora in Patients with Chronic Hepatitis B: A Controlled Cross-Sectional and Longitudinal Real-World Study","volume":"10","author":"Lu","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","article-title":"Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation","volume":"303","author":"Bajaj","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00248-011-9925-5","article-title":"Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease","volume":"63","author":"Xu","year":"2012","journal-title":"Microb. Ecol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cgh.2018.08.008","article-title":"Altered Microbiome in Patients with Cirrhosis and Complications","volume":"17","author":"Acharya","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jcar.JCar_9_16","article-title":"Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis","volume":"16","author":"Ghouri","year":"2017","journal-title":"J. Carcinog."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.semcancer.2014.01.004","article-title":"Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma","volume":"26","author":"Shlomai","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Milosevic, I., Todorovic, N., Filipovic, A., Simic, J., Markovic, M., Stevanovic, O., Malinic, J., Katanic, N., Mitrovic, N., and Nikolic, N.H.C.V. (2023). HCC tango-deciphering the intricate dance of disease: A review article. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216048"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.jhep.2004.11.014","article-title":"Management of patients with hepatitis B virus-induced cirrhosis","volume":"42","author":"Fung","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.21037\/jgo.2017.03.14","article-title":"Viral hepatitis and hepatocellular carcinoma: Etiology and management","volume":"8","author":"Zamor","year":"2017","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Derovs, A., Laivacuma, S., and Krumina, A. (2019). Targeting Microbiota: What Do We Know about It at Present?. Medicina, 55.","DOI":"10.3390\/medicina55080459"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"19355","DOI":"10.18632\/oncotarget.8466","article-title":"Distinctly altered gut microbiota in the progression of liver disease","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12072-021-10279-3","article-title":"Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer","volume":"16","author":"Deng","year":"2022","journal-title":"Hepatol. Int."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Jinato, T., Anuntakarun, S., Satthawiwat, N., Chuaypen, N., and Tangkijvanich, P. (2024). Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma. Appl. Microbiol. Biotechnol., 108.","DOI":"10.1007\/s00253-023-12845-1"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12967-023-03938-6","article-title":"Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues","volume":"21","author":"He","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Komiyama, S., Yamada, T., Takemura, N., Kokudo, N., Hase, K., and Kawamura, Y.I. (2021). Profiling of tumour-associated microbiota in human hepatocellular carcinoma. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-89963-1"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3350\/cmh.2024.0857","article-title":"Gut microbiota-mediated gut-liver axis: A breakthrough point for understanding and treating liver cancer","volume":"31","author":"Li","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/hep.29791","article-title":"Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41395-018-0085-9","article-title":"Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1177\/0300060518776064","article-title":"Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis","volume":"46","author":"Xia","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","article-title":"Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: A randomized, controlled trial","volume":"147","author":"Dhiman","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nut.2010.01.006","article-title":"Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study","volume":"27","author":"Pereg","year":"2011","journal-title":"Nutrition"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/apt.12695","article-title":"Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis","volume":"39","author":"Bajaj","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2013.11.006","article-title":"Probiotics prevent hepatic encephalopathy in patients with cirrhosis: A randomized controlled trial","volume":"12","author":"Lunia","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Shi, K., Zhang, Q., Zhang, Y., Bi, Y., Zeng, X., and Wang, X. (2023). Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.1104399"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MEG.0b013e3282f3e6f5","article-title":"An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy","volume":"20","author":"Sharma","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00268-021-06388-7","article-title":"Influence of Probiotics Administration Before Liver Resection in Patients with Liver Disease: A Randomized Controlled Trial","volume":"46","author":"Roussel","year":"2022","journal-title":"World J. Surg."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Wang, K., Yang, X., Wu, Z., Wang, H., Li, Q., Mei, H., You, R., and Zhang, Y. (2020). Dendrobium officinale Polysaccharide Protected CCl4-Induced Liver Fibrosis Through Intestinal Homeostasis and the LPS-TLR4-NF-kappaB Signaling Pathway. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00240"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jff.2018.07.029","article-title":"Olive oil combined with Lycium barbarum polysaccharides attenuates liver apoptosis and inflammation induced by carbon tetrachloride in rats","volume":"48","author":"Yun","year":"2018","journal-title":"J. Funct. Foods"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/5\/1053\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:25:23Z","timestamp":1760030723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/5\/1053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["microorganisms13051053"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms13051053","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]}}}